The specific NQO2 inhibitor, S29434, only marginally improves the survival of dopamine neurons in MPTP-intoxicated mice Maeva VallucciJean A. BoutinEtienne C. Hirsch Neurology and Preclinical Neurological Studies - Original Article 18 October 2023 Pages: 1 - 11
The role of immune and inflammatory-related indicators in cognitive dysfunction and disease severity in patients with parkinson’s disease Xudong ZhaoLei LiWeifeng Luo Neurology and Preclinical Neurological Studies - Original Article 20 October 2023 Pages: 13 - 24
A 12-month prospective real-life study of opicapone efficacy and tolerability in Emirati and non-White subjects with Parkinson’s disease based in United Arab Emirates Vinod MettaHuzaifa IbrahimK. Ray Chaudhuri Neurology and Preclinical Neurological Studies - Original Article Open access 05 October 2023 Pages: 25 - 30
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease Antonio CannavacciuoloGiulia PaparellaMatteo Bologna Neurology and Preclinical Neurological Studies - Original Article Open access 07 October 2023 Pages: 31 - 41
Botulinum toxin and conservative treatment strategies in people with cervical dystonia: an online survey Melani J. BoyceA. B. McCambridgeA. P. Verhagen Neurology and Preclinical Neurological Studies - Original Article Open access 13 October 2023 Pages: 43 - 51
Excessive psychological stress preceding the onset of idiopathic cervical dystonia Dirk DresslerBruno KoppFereshte Adib Saberi Psychiatry and Preclinical Psychiatric Studies - Original Article Open access 29 September 2023 Pages: 53 - 57
MAOA methylation is associated with impulsive and antisocial behaviour: dependence on allelic variation, family environment and diet Margus KanarikKatre SakalaJaanus Harro Psychiatry and Preclinical Psychiatric Studies - Original Article 29 July 2023 Pages: 59 - 71
Autophagy markers, cognitive deficits and depressive symptoms in Parkinson’s disease Yanzhe LiHechao YangJie Li Psychiatry and Preclinical Psychiatric Studies - Original Article 06 October 2023 Pages: 73 - 81
Subregion specific neuroadaptations in the female rat striatum during acute and protracted withdrawal from nicotine Oona LagströmEdvin VestinLouise Adermark Psychiatry and Preclinical Psychiatric Studies - Original Article Open access 27 July 2023 Pages: 83 - 94
The GlyT1-inhibitor Org 24598 facilitates the alcohol deprivation abolishing and dopamine elevating effects of bupropion + varenicline in rats Yasmin OlssonHelga LidöBo Söderpalm Psychiatry and Preclinical Psychiatric Studies - Original Article Open access 29 September 2023 Pages: 95 - 106